← Browse by Condition
Medical Condition

intracranial meningioma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06955169 Phase 2
Recruiting

Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment

Enrollment
153 pts
Location
United States
Sponsor
RTOG Foundation, Inc.
View Trial →